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···ABSTRACT··· 
Early feeding of low birth weight (LBW) infants with their own mothers' milk has 
been shown to decrease the incidence of oxygen radical related disease states. Milk from 
mothers of pre-term cPn and full-term (IT) infants may exhibit antioxidant and free radical 
scavenging ability not provided by humanized formulas. This study investigated the ability of 
milk from weeks 1, 2 and 12 oflactation ( 17 PT and 28 Fr mothers) to resist oxidative stress 
by free radical attack as compared to formula. The hypoxanthine/xanthine oxidase (HXIXO) 
system was utilized to generate the radicals and subsequent oxygen consumption was 
measured. The samples were also tested for catalase (CAT) activity, and for malondialdehyde 
(rvfl)A) levels by HPLC following stress. As well, normal (3 mg/L) and high (12 mgiL) iron 
formulas were tested for their ability to resist oxidative damage with and without the presence 
of added antioxidant enzymes CAT, superoxide dismutase (SOD) and glutathione peroxidase 
(GSHPx). There was no difference (p > 0.05) between the PT and FT groups with respect 
to oxygen consumption (nmoles 0/min) at any stage of lactation. The means± SEM of02 
consumption reported for the groups respectively following lOOXO stress, were for week 
one, 7.97 ± 0.56 and 6.68±0.88; for week two, 4.62 ± 0.42 and 5.17 ± 0.36; and for week 
twelve, 4.08 ± 0.39 and 4.80 ± 0.49. There was also no difference in MDA levels or CAT 
activity between groups. This indicates that PT mille has similar antioxidant capability as FT 
milk. A correlation (r= .443, p < 0.05) existed between 0 2 consumption and MDA levels, 
and a negative correlation (r= -0.30, p < 0.01) between the amount of oxygen consumed, 
and the activity of CAT for all weeks, demonstrating a possible protective role of this enzyme 
-tv-
in human milk (HM). A difference (p < 0.001) was reported in total 0 2 consumption 
(nmoles) over time between the HM (44.75 ± 1.66) and both the normal (98.88 ± 3.11)and 
high-iron ( 168.94 ± 9. 4 7) formulas. Addition of CAT, SOD and GSHPx together was shown 
to increase (p < 0.01) the antioxidant capacity of the normal and high-iron formula by 
decreasing the oxygen consumption to 66.11 ± 6.48 and 104.81 ± 8.65 respectively. 
Furthermore, the addition ofFe to HM resulted in an increase in 0 1 consumption compared 
to HM controls providing an indication of iron as a free radical generator in infant formula. 
There was no catalase activity detected in the formula and upon pasteurization of the HM to 
inactivate the enzymes, antioxidant capability was not compromised. 
-v-
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···CHAPTER 1: LITERATURE REVIEW··· 
Recently, oxygen-derived free radicals have become increasingly implicated in a wide 
variety ofhuman health problems (HalliweU, 1994). Free radical-mediated ceU injury occurs 
both in situations of increased radical exposure or in instances where the protective 
antioxidant systems are depleted or impaired. Much research is still required to produce a 
thorough understanding of specific free radical involvement in any particular disease, but 
current evidence clearly states that reactive oxygen species (ROS) often play a significant 
role. 
All classes ofbiological molecules are sites of potential ROS attack, especially in the 
LBW infant, where defense mechanisms are not fully developed and the patient is susceptible 
to increased oxygen stress. Newborn infants are faced with an abrupt change to a relatively 
hyperox.ic extrauterine environment where oxygen concentrations are five times higher than 
during intrauterine development (Stone, 1999). Because oxygen radicals can be generated 
as a consequence of acute and chronic inflammation (Baggiolini & Thelen, 1991 ), ischemia-
reperfusion injury (Oldham & Bowen, 1998.; Sokol & Hoffenberg, 1996), and various other 
environmental factors it is not surprising that free radicals and antioxidant defense 
mechanisms have been extensively studied [See figure 1.1]. 
Very little is known, however, about the antioxidant properties of HM and the 
possible ROS-antioxidant interactions. Buescher and Mcllheran (1988) have demonstrated 
the antioxidant properties ofhuman colostrum by its ability to deplete hydrogen peroxide and 
protect epithelial cells from polymorphonuclear leukocyte mediated damage. HM has 
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FIGURE 1.1 The source and generation of free radicals and ROS intermediates, 
and the enzymatic and nonenzymatic protective systems available to the cell. 
(From Roberts and Frank: Developmental consequences of Oxygen toxicity.) 
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also been shown to protect against the pathogenesis of necrotizing enterocolitis (NEC) 
(Marshall & Roberts, 1990). In the latter experiment it was demonstrated that upon 
pasteurization of the milk, protective effects were lost, leading to the hypothesis that 
enzymatic defenses that would be denatured by heat are vital to the milk's protective nature. 
Almass et. al. ( 1997), found that •oH production in breast milk in response to oxidative stress 
was lower compared to humanized fonnulas thus demonstrating an additional free radical 
sequestering ability. 
Human milk and infant formulas provide approximately the same level of 
nonenzymatic antioxidants such as vitamin E and vitarnin-€:--But--due to processing 
procedures such as pasteurization, the cow's milk used for the fonnula loses some of its 
functionality, namely enzyme activities, and therefore cannot provide enzymatic defenses to 
free radical attack. Enzymes such as SOD, GSHPx and CAT present in the mothers milk but, 
not in humanized fonnulas, may provide the same physiological protection as in other body 
tissues. Other, less prominent, enzymes such as myeloperoxidase and lactoperoxidase have 
also demonstrated antioxidant capability. It has also been shown that premature infants can 
absorb intact proteins, such as apolactoferrin (Sullivan, 1988) and boost antioxidant capacity. 
It may be that these predominant antioxidant enzymes in the mother's milk can also cross the 
neonatal gut intact and increase antioxidant status and prevent disease. 
The study of the antioxidant systems in HM in comparison with humanized formulas 
is important in understanding how these agents may provide protection against disease in the 
LBW infant which may experience significant oxidative stress in the first few weeks of life. 
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1.1 Reactive Oxygen Species 
A free radical is defined as an atom or molecule that contains one or more unpaired 
electron( s) in its outer orbital rather than the usual paired eledron spins found in most stable 
molecules (Sokol & Hoffenberg, 1996). An agent becomes a free radical then, by either 
gaining or losing an additional electron. Thus the free radical generally becomes very reactive 
as it attempts to re-establish a paired electron system by abstracting electrons from other 
molecules. ROS, on the other hand, include not only oxygen-centered radicals but also non-
radical derivatives of oxygen such as ~02 which may cause damage to body tissues. 
In the well condition the major source of ROS produced in the body occurs in 
mitochondrial and microsomal electron transport chains as 0 2 is reduced to superoxide (02 •-). 
Subsequent one-electron reductions may then take place to form other ROS as follows: 
e· e·+ :nr e·+ lr 
0 1 .... O:~ ·- .... u1o1 .... 
Each intermediate has the potential to initiate and propagate radical reactions with proteins, 
DNA and lipids. The most important ROS involved in biological systems are listed in Table 
1.1. 0 2 •- is the most commonly formed ROS during normal physiological processes. About 
1% to 3% of the 0 2 we metabolize is converted to 0 2•- (Oldham & Bowen, 1998). As 
demonstrated by figure 1.2 below, phagocytic cells may release an additional endogenous 
source of 0 2 •- during the inflammatory response (Kilgore & Lucchesi, 1995). Figure 1.3 
demonstrates how the antioxidant enzymes work in concert to significantly delay or inhibit 
the formation of harmful free radicals such as •oH and therefore prevent major tissue 
damage. During conditions of oxygen stress, if these defense mechanisms are available in 
adequate quantities in the developing LBW infant, tissue (lipid membranes, protein, DNA) 
damage will occur leading to the onset of oxygen radical-related diseases. 
1.1.1 Oxidative Stress 
The term free radical, when referring to oxidative stress may be more specifically 
described as an oxygen free radical or a reactive oxygen species (ROS). It is here that 
electron transfer reactions, or redox reactions, occur with oxygen as the central atom (Borg, 
1993). These radicals are central to the onset oftissue damage mediated by oxidative stress. 
Oxidative stress was defined by Seis ( 1985) as a disturbance in the pro-oxidant-
antioxidant balance in favor of the former leading to potential tissue damage. Under normal 
conditions the amount ofROS present at any specific time in tissue is extremely small relative 
to the corresponding concentration of oxygen. For example, the instantaneous concentration 
of a semi~reduced oxygen molecule in the brain (which consumes about 200/o ofthe body's 
oxygen) is estimated to be about 10 .n M (Floyd, 1993). Therefore, when all systems are 
functioning nonnally the weU infant has very little trouble dealing with the levels of 
endogenously produced free radicals. On the other hand, during situations of immature 
development, such as in the LBW infant, the infant may not be capable of withstanding the 
elevated levels of endogenous free radical production as well as the added stress applied by 
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TABLE 1.1 
Reactive oxygen species of physiological interest. 
(From Muggli, R. 1993.) 
REACTIVE OXYGEN SPECIES 
RecMc:.l Nllme Typlcel 
bkllagal c.rget 
~~ ~ Enzymes 
H202 I tydlogllii peroxide Unsalurated fatty acids 
HO" Hydroxyl AJ biomolecutes 
A" R-yl Oxygen 
AO" R-oxyl Unsaturated latty acids 
ROO" fWioxyl (R-peroxyl) UnsaturaiBd latty acids 
ROOH Hydl '4* oxide Unsaturased latty acids 
1o2 Singlet molecular oxygen ¥ 
NO" Nitroxyl Sewn~ 
FIGURE 1.2 Production of reactive oxygen species by 
phagocytic cells. (From Rice-Evans, 1995) 
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FIGURE 1.3 Antioxidant enzymatic pathways for reduction of 0 2 • - to H20 . 
(Modified from Sokol & Hoffenberg, 1996) 
the increased oxygen administration by supplementation due to poor lung development. 
Lubec et. al. (1997), state that hydroxyl radical attack may be the primary mechanism of 
injury responsible for the 
acute and chronic disease states in infants receiving long-term oxygen therapy. 
Fortunately oxygen itself does not react with biological tissues because of its stable 
triplet spin state. Its function physiologically is as a terminal electron acceptor during the 
formation of ATP and becomes fully reduced to water. It is the semi-reduced states of 
oxygen that are responsible for the oxidative damage that occurs (Floyd, 1993). Therefore, 
there needs to be a balance between the amount ofROS that are produced and the level of 
defense systems available to the tissue in order to prevent the onset oftissue damage. Certain 
conditions, imposed on the system however, as in the case ofLBW infants, may cause a large 
increase in the amount ofROS produced, thus causing in increased amount of oxidative 
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TABLE 1.1 
Possible facton and mechanisms for oDdative stress in 
premature infants. (From: Stone, 1999) 
OXIDATIVE STRESS 
• Prematurity 
• Ci1arette smokiq duriDa prepucy 
• Hypero:da therapy for respiratory distress 
syndrome 
• superoxide radicals 
• bydrosyl radicals 
• peros:ymtrite 
• Lack of adequate aatiosidut defease systems 
• deficieace or antiosidaat eazymes 
• vitaaaia E deficiency 
damage eventually leading to oxygen related disease of the immature neonate. Table 1.2 
illustrates some of the possible means by which oxidative stress may be incurred on a 
premature infant. 
1.1.2 Jschemiii-Reperfusion Injury 
Ischemia refers to a decreased supply of oxygenated blood to a body tissue or organ, 
and often results in tissue damage and organ dysfunction (Mosby's Medical Dictionary, 4* 
Ed., 1994). When tissues are deprived of oxygen they are injured, and after a certain period, 
the damage becomes irreversible. The duration of this period depends on the tissue in 
question and the extent of the oxygen deprivation (Rice-Evans, 1995). The main therapy for 
ischemia related injury is reperfusion of the deprived tissue with oxygenated blood. 
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Unfortunately, even though the reperfusion process is necessary to prevent ischemic death or 
tissue necrosis, it is also thought to be accompanied by its own component of injury (Omar 
et. al., 1991). Therefore both processes can be linked together as a single form of injury 
referred to as ischemia-reperfusion injury. 
During ischemia, anaerobic ATP generation is not sufficient enough to supply the 
normal metabolic requirements of the tissue cells, and thus ATP content of the tissue falls 
rapidly (Omar et. al., 1991). During the process of ATP metabolism, substrates and 
metabolic byproducts are formed such that, when reperfusion occurs, production of oxygen 
radicals will ensue and cause further tissue damage. The HXIXO system (figure 4) is one 
such mechanism that leads to the production of the 0 2 •· (Saugstad, 1988) and is commonly 
found in most tissues, especially the heart, GI tract, kidneys (Omar et. al., 1991 ), lungs, brain 
and retina (Saugstad, 1988). 
Ischemia-reperfusion injury plays an imponant role in oxygen related diseases of the 
LB W infant. Saugstad (1996) suggests reoxygenation injury results due to an explosive 
production ofROS generated by the HXIXO system, following hypoxia during the perinatal 
period. Following birth the LBW infant ftequendy has poor lung development which may 
temporarily leave the child deprived of oxygen, therefore requiring the necessary high levels 
of oxygen administration. Coupled with undeveloped defense mechanisms, these processes 
lead to the pathogenesis of oxygen radical related diseases such as bronchopulmonary 
displasia (BPD), retinopathy of prematurity (ROP), intraventricular hemorrhage (IVH) (Kelly, 
1993) and NEC (Clark et. al., 1988). 
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FIGURE 1.4 Proposed mechanism of reperfusion injury.(From 
Saugstad, 1988) 
1.2 Oxygen Related Diseases of the Neonate 
The following disorders are some of the most common oxygen radical-related diseases 
in the neonatal period. LBW infants are very susceptible to the development of these diseases 
after birth due to increased oxygen stress and underdeveloped defense mechanisms because 
of poor antioxidant protection. This section will briefly describe the special requirements of 
the LBW infant and some of the common diseases and their etiologies related to ROS, and 
to demonstrate how antioxidants play a role in preventing or prohibiting further development 
of the conditions. If antioxidant enzymes can be shown to play a beneficial role in dealing 
with such neonatal diseases as BPD, ROP, NEC and IVH, and these same enzymes are found 
in substantial quantities in mother's milk, there may be yet another added benefit to HM 
feeding rather than with artificial formula. 
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1.2.1 Requirements of the LBW lnftlllt 
The change from intrauterine life to extrauterine life for the LBW infant places 
enormous stress upon its respiratory and cardiac systems, along with increased stress in its 
thermoregulation capabilities (Ballard, 1991 ). The normal term infant can become stressed 
too, yet their bodies are more prepared for this change. In the fuU term infant, catecholamines 
contribute greatly to many processes that are important to the infant's adaptation at birth. 
These processes include "reabsorption of lung fluid, release of surfactant into the alveoli, 
mobilization of ready usable fuel for nutrition, defense against cold stress, and modulation 
of cardiac output to ensure preferential flow of blood to vital organs, such as the lungs and 
brain" (Ballard, 1991 ). In a LBW infant, the levels of catecholamines are much lower than 
those of a full tenn infant. 
Once an infant is born, the primary concern is to establish a patent airway, proper level 
of oxygen saturation, and a stable respiratory status because the infant lung has not yet fuUy 
matured. To avoid hyperoxia, the oxygen blender should be set at 40% oxygen when 
resuscitation has begun, as compared to 1 000/o as used in the SO's and 60's, and then turned 
down as quickly as possible as the infant tolerates. It should only be increased to 100% if the 
infant shows clinical signs of cyanosis of the skin or other respiratory malfunctions (McAteer, 
1997). 
Once the infant has been stabilized and placed into an isolette, the plan of care is 
outlined for each individual infant. Even though each plan of care is different, there are 
general guidelines that should be foUowed when caring for a LBW baby. Keeping in mind 
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that increased physiological stress in the infant can cause a decrease in oxygen saturation and 
lead to ischemia-reperfusion, it is important to minimize the amount of handling the infant 
undergoes. Minimal handling can be achieved by centering activity such as obtaining vital 
signs, turning and positioning, and feeding around the infant's sleep-wake cycle. Controlling 
the noise levels and the temperature of the environment can also maintain adequate stress 
levels for the infant (Weaver, 1991). 
Minimal handling does not imply minimal care. The observation skills of the primary 
care giver with respect to infant's behaviors and responses to its environment are key 
indicators in detecting something may be wrong with the infant. Any sudden change in color, 
tone, feeding patterns, and activity warrants the attention of the physician. Nutrition is also 
very vital in ensuring recovery from disease maintaining the integrity of the VLBW infant 
(Kovar et. al., 1984). As a result HM is becoming more recognized as a primary feeding 
choice for these infants. 
1.2.2 Bronchopulmonary DisplasUI 
Also referred to as chronic lung disease, this disorder develops in infants partially due 
to administration ofhigh concentrations of oxygen to immature lungs (McAteer, 1997). BPD 
most likely complicates the respiratory distress syndrome found in most LBW newborns. It 
has been estimated that between 20 and 45% of infants born prior to the 321111 week develop 
the condition (Kelly, 1993). With classical BPD, destructive inflammatory changes in the lung 
tissue eventually lead to the destruction of alveolar walls and bronchiolar epithelial linings 
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(McAteer, 1997). The condition therefore results in an increased need for oxygen 
administration , thus adding to the problem of excess oxidative stress. 
New research poses a view that reactive oxygen species may be largely responsible 
for the clinical events associated with BPD development. Studies by Varsila et. al. (1995), 
and later Ogihara et. al, (1996) provide evidence of the involvement ofROS in triggering 
BPD and oxidation of protein leading to BPD respectively. Furthermore, Rosenfeld et. al. 
(1984), before any true evidence of ROS involvement in BPD development and the 
observation of their role in general inflammation, demonstrated that BPD could be prevented 
upon the administration of SOD. 
1. 2.3 Retinopathy of Premtltll'ity 
Retinopathy of prematurity, or retrolental tibroplasi' refers to the formation of 
fibrous tissue behind the lens and on the retina of the eye, resulting in blindness This disorder 
is caused by various factors, including administr&tion of excessive concentrations of oxygen 
leading to high oxygen levels in retinal vessels premature newborns (Mosby's Medical 
Dictionary, 1994). Most cases occurred during the time when technology did not permit the 
clinician to assess appropriate inhaled oxygen concentrations, thus many babies lost their 
eyesight before the association with oxygen was determined (around the 1960's) {Kelly, 
1993). ROP has also been liked with the formation ofROS during ischemia reperfusion of the 
retinal capillaries as the retinal wall thickens. 
The relationship between HM feeding and the development of ROP has been 
examined. Uauy et. al. ( 1990) demonstrated a significant improvement in retinal development 
in infants receiving HM as the primary feeding source, and later, Birch et. al. (1993) 
confirmed the relationship between breastfeeding, and components ofHM, and optimal visual 
development. 
1. 2. 4 Necrotizing Enterocolitis 
Necrotizing enterocolitis is a disease of the neonate characterized by necrosis of 
the bowel and is a significant cause of death in the LBW infant population. 800/o of the infants 
with NEC are LBW newborns and the incidence increases with decreasing gestational age 
(MacKendrick, 1993). NEC is the most common serious gastrointestinal disease seen in 
neonatal intensive care units (Stoil, 1980). Clinical manifestations of the disorder include 
lethargy, abdominal distension, temperature instability and inability to feed. X-ray indicates 
tissue damage to the GI tract and bubbles of gas in the intestinal wall (McAteer, 1997). 
Oxygen-derived free radicals, particularly 0 2--, are important mediators of intestinal 
tissue injury induced by ischemia-reperfusion (Clark et. al, 1988). Such is the case with NEC. 
Gastrointestinal hypoxia and later reperfusion of oxygen has resulted in the development of 
oxygen-derived free radicals leading to intestinal tissue damage in the LBW infant causing the 
development ofNEC (Clark et. al., 1988, Granger et. al. 1996). This reasoning is supported 
by Babbs ( 1992) in a review of oxygen radical mediated ulcerative colitis. 
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There are many separate studies that have suggested that HM feeding provides 
protection from the development and/or worsening ofNEC. Lucas & Cole (1990), found that 
babies fed breast milk had observed a sharp decline in incidence of NEC and infants who 
received only formula developed NEC at a rate six to ten times higher than their HM-fed 
counterparts. A study by Benhamou et. al. ( 1998) has shown protection by breastfeeding 
against severe gastric lesions in the neonate, and suggests that breastmilk contains substances 
which provide protection against inflammation. More research is required to determine the 
effect of antioxidant enzymes on NEC protection. 
1.2. 5 Intraventricultu Hemorrhage 
Intraventricular hemorrhage is a condition resulting from bleeding into the ventricles 
of the brain due to rupture of the thin walled capillaries surrounding them. It remains one of 
the most important causes of permanent and devastating disability in the sick LBW infant 
(Kelly, 1993). The rupture of the capillaries is thought to result from increased cerebral blood 
flow following a state of hypoxia (McAteer, 1997) that occurs during the perinatal process. 
The ischemia-reperfusion process may lead to the formation of ROS and hence result in 
damage to the capillaries causing the rupture and bleeding into the ventticles of the brain. 
Much research is required on the involvement of llOS in the development of IVH, and the 
possible preventative role of antioxidants. 
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1.3 Feeding the Premature Infant 
Adequate nutrition is essential for the development and weD-being of the newborn, 
especially the premature infant. LBW infants require specialized nutritional support because 
of a high degree of biochemical immaturity, fast growth rates, and a greater incidence of 
medical complications (Pereira, 1995). This section briefly reviews the present clinical 
methods of feeding the LBW infant and the developmental status of the developing infant gut, 
and evaluates the general benefits of breast-feeding in contrast to artificial formula 
administration. 
1.3.1 Clinical Feeding Practices 
The precise nutritional requirements for LBW infants are highly debated and not weD 
established. The Committee on Nutrition of the American Academy of Pediatrics ( 1985) 
suggests that the ideal diet for LBW infants is the one that supports growth at intrauterine 
rates, without imposing stress on the infant's immature metabolic and excretory functions. 
Immediately foUowing birth, and during the first few days of life, the goals for 
nutritional support are the maintenance of fluid status, glucose homeostasis and electrolyte 
balance (Pereira, 1995). Since LBW newborns are suscept1ble to many fonns of water loss, 
due to the high surface area to volume ratio, radiant warmers and urine excretion (McAteer, 
1997) they require a balanced fluid intake. As weU as body fluid requirements, sick LBW 
infants in particular have decreased body stores of nutrients when compared with their Fr 
counterparts and require nutritional support in the form of parenteral feeding to prevent 
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weight loss and promote postnatal growth. Pereira (1995) states that even though most LBW 
infants are maintained on total parenteral nutrition (TPN) for several days after birth, an 
attempt should be made to begin enteral feeding of a milk as soon as the gastrointestinal tract 
is functional. It is at this stage that the choice offonnula or mother's milk administration can 
play a role in the prevention and/or development of oxygen related diseases. 
It is presently common practice to begin enteral feeding in small amounts until the gut 
develops. Gastric gavage is the preferred method of enteral feeding to LBW infants who 
cannot be fed orally because the sucking and swallowing reflex has not yet developed 
(McAteer, 1997). This method allows the infant to benefit from any properties that the HM 
or PT formula may afford. If mother's milk is not available, premature infant formulas are 
the best substitute, and which contain a higher concentration of protein, vitamins and minerals 
and trace elements than regular infant formula. 
6.2 General BenefitS of H11m1111 Milk Feedillgfor the LBW lnflllll 
Mother's own milk is the most suitable form of feeding for the LBW infant because 
the composition of the milk produced is designed to meet the specific needs the premature 
newborn possesses. Premature milk exhibits increased bioavailability of nutrients, 
immunologic properties, hormones, enzymes and growth facton (Pereira, 1995) which allow 
it to provide protection and suitable growth and development for the infant. A study by 
Narayanan et. al. (1981) demonstrated the value ofHM in the prevention of general infections 
in the high-risk low birth weight infant. They observed that infections were fewer in babies 
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who received expressed HM compared to those receiving the nursery formula Gastric 
emptying is also found to be faster following the feeding ofHM than with commercial bovine 
formula, and gastrointestinal growth and motility is enhanced due to increased postprandial 
plasma hormone concentrations (Schanler, 1995). An extensive review by Kovar et. al. 
(1984) also attnoutes lower infant mortality, decreased disease-specific morbidity, and lower 
rates of allergic disease to feeding HM to the LBW infant. They also attribute increased 
psychological and intellectual development of the baby to mother's milk feeding. Meier and 
Brown ( 1996), also elude to the health benefits of breastfeeding for mothers and LBW 
infants, including protection from NEC, protection from infection, greater feed tolerance, 
reduced risk of later allergy and enhance neurocognitive development. 
Can mothers ofLBW infants breastfeed? According to a prospective study by Byrne 
and Hull ( 1996) who examined the breastfeeding intentions and achievements of mothers of 
infants born prematurely, over 600/o of mothers succeeded in producing milk for their infants, 
including those of 28 weeks gestation and less. They also stated that many more mothers 
might do the same with more encouragement and improved facilities in neonatal units. On 
the other hand, the volume of milk expressed initially is generally small which often leads to 
slower growth rates than the baby's full-tenn counterpart, indicating that it is often necessary 
to supplement the HM administration following the feeding with a nutrient-rich formula 
fortifier (Schanler, 1995). Whatever the case, the evidence clearly shows that feeding the 
LB W infant with any quantity of mother's milk provides numerous benefits above and beyond 
commercial formula feeding. 
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1.4 Antioxidant Properties of Human Milk 
Human milk is presently considered to be the best food source for infants (Byrne & 
Hull, 1996). It is well known for its anti-inflammatory and anti-allergenic properties, and for 
its ability to provide protection for the developing infant gut. Recent research has 
demonstrated increased antioxidant capabilities ofHM as compared to formula. Goldman et. 
al. ( 1990), state that antioxidants in general are either absent or poorly represented in cow's 
milk or other artificial feedings, and that attainment of adequate plasma antioxidant levels in 
the new born is dependant upon HM feeding. Buescher and McDheran (1988) have reported 
on the antioxidant properties of human colostrum, demonstrating that HM exhibits 
antioxidant capabilities by being able to spontaneously reduce cytochrome c and deplete ~02 
produced by phagocytic cells and thus prevent damage to epithelial cells. Almass et. al. 
( 1997) demonstrated that •oH production in breast milk, in response to imposed oxidative 
stress, was lower compued to humanized formulas upon measurement of ROS production 
in both groups in vitro. They stated that HM appeared to contain '4substances" that reduce 
the formation of •oH. 
Formula feeding, on the other hand, has been shown to place infants at risk for oxidant 
stress due to excessive intakes of iron and vitamin C (Marshall & Roberts, 1990), and 
riboflavin (Friel et. al., 1996) which may lead to excess free radical production. Even though 
artificial formulas are fortified with ample levels of small molecule antioxidant scavengers 
such as vitamin E, they are not capable of demonstrating antioxidant enzyme capabilities 
comparable to untreated HM. 
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1. 4.1 Antioxidant Enzymes 
Human milk proteins such as apolactoferrin (Sullivan, 1988) and sulfhydryl oxidase 
(Isaacs et. al., 1984) have been found intact and active in the premature infant gut and feces. 
Thus it is possible that other proteins, particularly the antioxidant enzymes, may be stable in 
the GI tract and absorbed intact and capable of improving the antioxidant status of the LBW 
infant. The main enzymes ofinterest in HM are superoxide dismutase, glutathione peroxidase 
and catalase. 
Superoxide Dismutase 
Superoxide dismutase is responsible for the catalysis of the reaction responsible for 
conversion of two molecules of 0 2 •- to ~02 and the regeneration of 0 2. There are three 
forms of SOD; copper-zinc, manganese, and iron. Copper-zinc and manganese SOD are 
found in eucaryotic ceUs (mcluding human) in the cytosol and mitochondrial matrix 
respectively, whereas iron-SOD is found in bacteria (Florence, 1992). AU three fonns 
catalyze the same reaction with similar efficiency. 
The general catalytic reaction for SOD at physiological conditions is demonstrated by 
the following reaction: 
a:+ 
o1·- + o1• -.... Oz + H101 
CuZnSOD has been extensively studied for its antioxidant properties and protection 
against disease, including prevention of motor neuron degeneration (Gurney et. al., 1994) and 
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ALS in adults (Wiedau-Pazos, 1996) and treatment for BPD in infants (Rosenfeld et. al., 
1984). This enzyme seems to be the fint line of defense against ROS and can be rapidly 
induced during periods of oxidative stress (Michiels et. al., 1994). 
There is presently very little knowledge pertaining to the level and activity of SOD in 
milk of mothers of both LBW and full term infants. One preliminary communication by 
Willinger et. al. ( 1990) examines the difference in SOD activity between the two groups, and 
an ongoing study by Friel et. al. (1998, Personal communication) demonstrates the first 
systematic analysis of SOD in longitudinal samples ofHM from mothers ofPT and FT infants. 
Both these studies expressed SOD activity in Unitslml and Units/mg protein and found that 
activity was higher in theFT group ( 4.8 U/mg protein) than the PT group (3 .2 U/mg protein), 
and the latter showed increasing SOD activity over time. SOD activity in humanized fonnula 
is absent due to the pasteurization temperature during processing of the cow's milk. 
The high activity of SOD in HM as compared to infant fonnula suggests a possible 
functional or protective role of this antioxidant enzyme. For example, such evidence can be 
seen in the previously mentioned study by Rosenfeld et. al. ( 1984), where SOD administration 
was seen to prevent the formation of BPD in infants. Detection of the enzyme involves a 
slight modification of the method by L' Abbe and Fischer (1986) to account for the 
interference of myeloperoxidase in the milk, which may also cause reduction of the 
cytochorome c used in the assay. 
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Glutathione Peroxidase 
With the label, 'peroxidation-inhibiting protein', GSHPx is responsible for protecting 
cells from further oxidative damage and repair oflipid peroxides formed in the cell membrane. 
The function of GSHPx is dependant upon levels of GSH, glutathione reductase (GR), 
N ADPH and selenium in the cytosol and mitochondrial matrix of the ceU. This system works 
cooperatively to ensure there is a constant supply ofGSH in the medium and hence a reducing 
atmosphere (Scaduto, 1990). For example, Scaduto (1990) demonstrates the importance of 
the GSH system in ischemia reperfusion. GSHPx has also been found to reduce the enhanced 
susceptibility to lipid peroxidation of plasma and LDL in kidney transplant patients (Hussein 
et. al., 1997). 
The main function of GSHPx is to catalyze the oxidation of reduced glutathione to 
glutathione disufide (GSSG), and by doing so, reduce any unwanted hydroperoxides or 
organic peroxides. These two reactions can be written as follows (pH 7, 3 7' C): 
2GSH + H10 2 -+ GSSG + 2820 k = 10' M-1 s·• 
2GSH + ROOB -+ GSSG + ROB + H10 
ROOH in the second reaction may be a lipid peroxide formed from previous free radical 
propagation (Monday & Winterboume, 1989) or may be a form ofxenobiotic compound such 
as the metabolic by-product of acetaminophen (Mirochnitchcnko et. al, 1999). 
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There is a strong correlation between selenium concentration and GSHPx activity in 
HM (Hamosh, 1995). The milk enzyme is 9()0/o immunologically identical to the plasma 
enzyme and acts in the same fashion catalytically. It was observed by Ellis et. al., (1990) that 
the activity of the enzyme in milk of mothers of LBW infants paralleled changes in PUF A 
content over the course oflactation, demonstrating a possible function of the GSHPx in milk 
lipid protection from oxidation, or for oxidative repair. Hamosh states that the enzyme could 
also maintain the integrity of the milk by neutralizing the damaging action of oxidants that 
could be produced by the activity of other milk enzymes such as SOD. 
Mannan and Picciano (1987) reported a mean GSHPx activity of77.1 units/liter for 
HM: in lllinois subjects, and Funk et. al. ( 1990) reported a similar value of 51 .0 units/liter in 
HM: of African women. In an ongoing study by Friel et. al. (1998, Personal Communication) 
GSHPx levels in milk from mothers of PT and FT infants were compared. This group 
reported values of73.0 mU/ml (9.8 mU/mg protein) and 85.8 mU/ml (8.4 mU/mg protein) 
for the PT and FT groups respectively. There is only one other longitudinal study examining 
GSHPx activity in milk from mothers of pre term and fuU term infants. This is the previously 
mentioned study by Ellis et. al. (1990). There is much work to be done to fully understand 
the antioxidant capabilities of CAT in HM 
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Catalase 
Like the other antioxidant enzymes, CAT has also been implicated in the prevention 
and/or treatment of various human health disorders, such cell survival against 0 2 stress 
(Michiels et. al., 1994), ischemia-reperfusion injury and BPD (Grisham et. al., 1990). 
CAT activity in cow's milk has been extensively researched in the field of Dairy Science as 
an indicator of shelf life for cheese products (Hirvi & Griffiths, 1998), but very little is known 
about the levels of CAT in HM and possible antioxidant properties provided by this enzyme. 
CAT is responsible for catalysis of the foUowing reactions: 
2H10 1 --. 2810 + 0 1 
ROOH + AB1 --. 8 10 + ROB + A 
Heyndrickx (1963) reported CAT activity in HM to be about 10 times greater than 
unprocessed cow's milk. Research is presently being performed to learn more about the CAT 
system in mother's milk and the possible beneficial antioxidant properties for the newborn. 
The enzyme has been found to be absent in infant formulas and has a very low activity in 
fresh, unprocessed cow's milk, thus supporting Hendrickx' observations in 1963. 
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1.5 Problem of Investigation 
The major enzymes involved in the detoxification of reactive oxygen species and lipid 
hydroperoxides include CuZn SOD, GSHPx, and CAT. In the absence of adequate 
endogenous antioxidant defenses, and under added oxygen stress, the propagation of free 
radical events in LBW infants can lead to the co-oxidation of nucleophillic cellular 
constituents as weU as reaction of secondary lipid oxidation products with other constituents 
such as protein and DNA (Yuan & Kitts, 1997), thus leading to the onset of various forms of 
disease. 
The purpose of the present study was to detennine the antioxidant propenies ofHM 
as compared to humanized infant fonnula, and to make recommendations on both the present 
neonatal feeding practices and general overall health benefits of breast feeding. The 
hypotheses and objectives for this study are outlined below: 
+ Hypothesis 1: Pre-term human milk may exhibit increases antioxidant and free ndical 
scavenging ability compared to full-term human milk, thus supporting it as the feeding 
method of choice for at-risk low birth weight infants. 
Objt!ctillt! 1: To determine the ability of pre-term human milk to resist oridative 
stress as compared to foil-term mille at the same period of lactation. 
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+ Hypothesis 2: The antioxidant potential ofhurnan milk from mothers ofpre-tenn and 
fuU -term infants is partially attributed to the presence of the antioxidant enzymes, 
catalase, superoxide dismutase and glutathione peroxidase. 
Objt!ctiv~ 2: To determine if the increased antioxidant status of human mille is 
partly attributed to the presence of the antioxidant enzyme systems comprised of 
catalase, superoxide dismutase and glutathione peroxidase [see figure J}. 
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··· CHAPTER l: MATERIALS AND METHODS ··· 
2.1 Subject Demographics and Sample CoUection 
Milk samples for this study were coUected from 17 mothers of FT infants and 28 
mothers of PT infants once a week beginning on the first day of lactation and continuing 
weekly for 12 weeks. Each sample was coUected by the mother using a manual pump or by 
hand expression and transported on ice to the laboratory and immediately frozen and stored 
at -70 degrees Celsius until thawed for analysis. Samples from weeks one, two and 12 were 
analyzed for the ability to resist stress imposed by 0 2._. CAT specific activity. 'MDA levels 
after stress and oxidative stress resistance following iron addition. 
Low birth weight refers to infants who weigh less than 2,500 grams at birth and are 
usually born prematurely(< 37 weeks gestation). The average birth weights (mean± SEM) 
of the pre-tenn and fuU-tenn infants were 1810 ± 135 g and 3753 ± 132 g respectively, and 
the average gestational age was recorded as 32 ± I weeks and 39 ± I weeks respectively. 
There was no significant difference between the mothers' ages in the two groups (Table 2.1 ). 
2.2 Experimental Design 
The samples in this study were analyzed both longitudinally within groups to 
determine the change in experimental variables throughout the period of lactation, and 
between groups as a comparison of means to detennine if any differences exist between PT 
and FT milk (Figure 5). Both groups were subsequendy compared with infant formula under 
the same test conditions in an attempt to understand the increased antioxidant capability 
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TABL£2.1 
Study subject demographics 
Pre-Tenn Fu-11- Term 
Number of Subjects 28 17 
Mother's age (yrs) 29 +/-1 31 +/- 1 
Gestational age (wks) 32 +/·1 39 +/- 1 
Baby's Birth Weight (g) 1810 +/-135 3753 +/-132 
Values are~~~~~ +1- SEM 
Human Milk Infant Formula 
/~ 
PT 
I 
I 
i 
I y 
Enzyme 
activities 
Fe & Vit C 
addition 
FT 
Resistance to 
0 2 Stress 
/~ 
Low Fe 
MDA analysis 
after stress 
High Fe 
Enzyme Addition 
Fe binder 
FIGURE 1.1 Flowcban demonstrating experimental design of study. 
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previously determined in HM. Furthermore, modifications were made to both the HM and 
formula to determine the action ofROS and antioxidant enzymes under various conditions. 
2.3 Methods 
2.3.1 Oxygen Stress 
2.3.1.1 Antio:ridaat Capacity Usia& the (bypa MoDitor 
Purpose: To determine the ability of HM to resist oxidative stress by free radical 
generation via the HXIXO system. 
Theory: The HXIXO system is a free radical generating system found in the infant gut 
[see figure 1.4]. XO catalyzes the reaction ofHX and Oxygen to produce 0 2•-. Therefore 
the rate of consumption of oxygen measured on the chart recorder corresponds to the ability 
of the milk to resist the stress incurred. 
Method: Resistance of milk samples to oxidative stress was measured 
polarigraphically as a modification of the method outlined by Hirvi and Griffiths ( 1998), using 
a Clark-type oxygen electrode and a YSI 5300 oxygen monitor equipped with a chan 
recorder. Calibration of the electrode, before use and several times during the period of use, 
was done by the addition of air-saturated water to the reaction chamber with the magnetic 
stirrer on and by adjusting the sensitivity control of the polarizing circuit to give a full-scale 
deflection on the chart recorder. The value for zero oxygen was determined using sodium 
sulfite, and was equivalent to the electronic zero of the system .. 
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The reaction was canied out at 37° C and the value of 226 nmol oxygenlml 
(Handbook ofChem & Phys 40111 Ed.; VanSlyke et al, Handbook ofRespiration) was used 
for calculating oxygen consumption at this temperature. The sensitivity control was adjusted 
to set the baseline to 90 % and chart speed was set to 10 mm/min. 
After calibration the water was removed and 1350 ~I each ofHM sample (or formula) 
and phosphate buffer (pH 7.4, 100mM) were added direaly to the same chamber. The 
electrode was reinserted and the magnetic stirrer turned on and allowed to equilibrate to 3 7 o 
C . Once a baseline was established (approx. 3 min), 300 J.'l ofHXIXO solution (50 mM and 
25 mU/ml final concentrations respectively; 30: 1) was added to the reaction mixture using a 
syringe through the overflow pore in the plunger. Oxygen consumption was monitored for 
about 5 min and the slopes were read immediately before and after the HX!XO addition. 
Calculation: l. Determine the nmol of oxygen/min for the before and after slopes. 
- multiply the calibrations/min by the nmoVcalibration determined during setup (measured to 
be 2.26 nmoVml). 
- caVmin x 2.26 nmol 02/calibration = nmol 02/min. 
2. Subtract the before value from the after value to detennine the true effect of 
HXIXO.addition. 
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2.3.1.2 Malondialdehyde by HPLC 
MDA is still the most widely used measure oflipid peroxidation despite its limitations, 
and can be cheaply and easily determined by the thiobarbituric acid (TBA) reaction. The 
method has been described previously for urine and plasma MDA in pre-term infants by Dnuy 
et. al. ( 1997) and modified here for milk analysis by incorporating a centrifugation step prior 
to sample injection to remove casein. The introduction ofbutylated hydroxytoluene (BIIT), 
a common antioxidant, to prevent the formation of MDA by lipid decomposition during the 
assay, along with chromatographic separation by HPLC has been shown to improve the 
accuracy of the experiment. 
A Beckman II 0 pump, Kratos FS970 Fluorometer set at 5 25 nm, Hewlett Packard 
3390A Integrator, Waters CIS, 3.9 x 150 mm CIS Symmetry HPLC column and guard 
column were used. The mobile phase was 60:40 phosphate buffer (pH 6.8, SO mM) and 
methanol respectively, set at a flow rate ofO. 75 ml/min. The column was washed overnight 
with 20% methanol and purged on a regular basis with 1000/o methanol. 
To 390 J.tl of whole milk sample was added 375 J.ll 0.44 M phosphoric acid, 125 J.ll 
0. 6% TBA, 10 J.LI BHT (2% in ethanol) and the remaining volume of water for a total volume 
of 1 ml. Samples were vonexed and incubated at 98°C ± 1 oc for 60 min and immediately 
placed on ice until analysis. All samples were filtered using 0.22 J,Lm pore luer-fitting filters 
before injection. l 00 J,tl of sample was injected to rinse and for analysis in each case. 1, 1,3,3-
Tetraethoxypropane was used to develop a standard curve for each assay and a correlation 
coefficient ofR2 = 0.998 was obtained. 
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2.3.2 AntioxidiUit capabilities of lt1111UU1 milk IUidformMIII 
Z.3.2.1 Catalase Specific Activity 
Purpose: To detennine the activity of CAT in HM. 
Theory: 1 unit of CAT is defined as the amount of enzyme required to decompose 1 
umol ofH20 2 per min at 25° C. 
2 8 10 1 -. l 0 1 + 2 8 20 
Method: CAT activity was measured polarigraphically by modification of the method 
by Hirvi and Griffiths ( 1998), and calibration of the system was performed as with the method 
of oxygen stress outlined above. The reaction was carried out at 25 o C. 
After calibration, 3 ml oftris buffer (pH 7.0; 100mM) and 30 .ul ofHM sample were 
added directly to the chamber and the electrode inserted and stirrer turned on. A portion of 
the same milk sample was set aside for protein estimation. Once a base line was established 
on the chart recorder (approx. 1 min), 150 .ul of 3% (voVvol) Rz02 was added and the 
oxygen evolution was monitored for about 2 min using the chart recorder set at a chan speed 
of0.5 mrnlsec. The initial rate ofincrease in the concentration of oxygen was calculated from 
the resulting slope. 
Calculation: 1. Read initial slope from chart recording (calibrations/min). 
2. Multiply by the Oxygen value of each marking detennined during cah"bration - ex: 
2.59 nmol oxygen/calibration. This will give the rate of oxygen production (nmoVmin). 
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3. Multiply by 2 for the stoichiometric ratio in the formula above. This will give the 
rate of hydrogen peroxide decomposition (nmoVmin). 
4. Divide by 1000 to determine umoVmin oflr;drogen peroxide which corresponds 
to units of catalaselml in the chamber. 
5. Multiply by the dilution factor (in this case 1 OOx) to determine the units of 
catalase/ml in the original sample. 
Protein Estimatio11: Milk protein determination was performed using the Lowry assay 
and the F olin-Ciocalteau reagent with bovine serum albumin ( 1 mglml) as standard. 
Spectrophotometric measurements were taken at 750 nm. A slight modification involved 
sample dilution to reduce particle interference caused by casein during measurement. A 
conunercial infant formula of known protein concentration was used as a control. 
2.3.2.1 Pasteurization of HIIIIWI Milk 
Milk samples were pasteurized in a hot water bath for S min at 85 oc and tested for 
the ability to resist oxidative damage before and after heat treatment. This temperature was 
required to achieve > 95% inhibition of CAT and GSHPx activity (determined 
spectrophotometrically by modification of method previously descn"bed by Paglia & 
Valentine, 1967) . Literature values also suggest that a temperature of75 oc is sufficient for 
inactivation of SOD. 
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2.3.2.3 Enzyme additioa to infaat formula 
The HM antioxidant enzymes CAT, SOD and GSHPx (final concentrations were 
based upon physiological levels found in HM: lS U/ml, 35 U/ml, and 0.10 U/ml respectively) 
were added to both normal iron (Similac Special Care 24, 3.0 mg/L; Similac Advance, l.S 
mg!L, Ross Laboratories, Ohio) and high iron (Similac Special Care 24, 14 mgiL; Similac 
Advance, 12 mg/L, Ross Laboratories, Ohio) neonatal formula to determine their ability to 
provide protection against oxidative stress by the HX/XO method previously described. 
Oxygen consumption was recorded for S min prior to the addition of the HXIXO and 
continued for a total of 20 min. The total oxygen consumed (nmol) was determined before 
and after the addition of enzymes. 
To detennine the viability of the antioxidant enzymes in formula, recovery experiments 
were performed and demonstrated no significant loss in CAT and GSHPx activity. Upon 
addition to the formula, the enzymes maintained greater than 9QO/o activity. 
2.3.2.4 Iron addition to Humaa milk 
Human milk was adjusted to final concentrations of 12 mg/L iron in the form of iron 
sulfate and 80 mg/L ascorbic acid to comparable levels recorded for common high iron 
formulas. Samples were then stressed with HXIXO for 20 min and compared against HM 
controls and HM containing ascorbic acid but not iron. Total oxygen consumption (nmol) 
was recorded and used to determine the effects of iron and ascorbic acid on the production 
of ROS and subsequent antioxidant resistance of the HM to added oxidative stress. 
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2.4 Statistical Analyses 
Two-tailed independent samples t-test, using Levene's test for equality of variances, 
and two-way analysis ofvariance were performed to detennine differences between groups, 
with the support of the Mann-Whitney U-test. Group descriptives were expressed as mean 
± SEM. Pearson Correlations were used to express relationship between variables. All 
analyses were performed with p < 0.05 taken as significant using the statistical package SPSS 
(version 9 .0). 
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··· CHAPTER 3: RESULTS ··· 
3.1 Oxygen Stress Resistance (Antios..idant Capacity) 
The ability of the milk to resist oxidative stress caused by the formation of the 
superoxide radical was the main study variable used to determine the relationship between 
samples from mothers ofPT and FT infants, and to investigate whether the PT milk exhibited 
enhanced antioxidant capabilities. Both groups, however, demonstrated no significant 
difference at any stage of lactation measured (figure 3.1 ) . The means± SEM reported for the 
pre-term and full-term groups respectively, for the consumption of oxygen (nmoles/ml) during 
HXIXO stress, wereforweekone, 7.97±0.56(n=22) and6.68±0.88{n=14); for week two, 
4.62 ± 0.42 (n=l2) and 5.17 ± 0.36 {n=l3); and for week twelve, 4.08 ± 0.39 (n=l3) and 
4.80 ± 0.49 (n=16). 
There was a notable decrease in oxygen consumption {nmoleslml) during stress after 
week 1 of lactation as compared with week 2 (7.46 ± 0.49, n=36; 4.90 ± 0.27, n=25; p < 
0. 00 1) when the values for both groups are combined {figure 3 .2), but no significant change 
between weeks 2 and 12. 
3.2 Malondialdehyde Levels FoUowing Stress (Lipid Damage) 
:MDA levels were determined as an estimate of the amount of lipid damage inflicted 
upon the milk samples during oxidative stress. Both the PT and FT groups provided the same 
protection against potential free radical damage. The means ± SEM observed for MDA 
(umoVL) for the PT and FT groups respectively after addition ofHXIXO (figure 3.3) 
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were for week one, 0.58± 0.08, n=14 and 0.72 ±0.11, n=8; for week two, 0.64±0.07, n=l2 
and 0.58 ± 0.08, n=lS; and for week twelve, 0.42 ± 0.09, n=11 and 0.27 ± 0.06, n=l6. Thus, 
there was no significant difference observed between the groups with respect to MDA levels 
at either week I, 2 or 12 oflactation. 
There was no initial decrease in MDA levels from week I to week 2 in combined 
values (figure 3.4), but a significant decrease was observed from week 2 to week 12 of 
lactation (0.60 ± 0.05, n=27; 0.32 ± 0.05, n=28, p < 0.001). 
3.3 Catalase Specific Activity 
The means± SEM reported for the specific activity (Units/mg protein) ofCAT in the 
PT and FT milk samples respectively for weeks 1 {0.50 ± 0.08, n=l2; 0.43 ± 0.05, n=8), 2 
(0.72 ± 0 .10, n=ll ; 0.82 ± 0.13, n=14) and 12 (0.97 ± 0 .21, n=13; 0.84 ± .12, n=l6) of 
lactation demonstrated no significant difference between groups {figure 3.5). The combined 
values (figure 3.6) of each group showed an increase in specific activity (unitslmg protein) 
over time of lactation from week 1 to week 2 (0.47 ± 0.05, n=20; 0. 78 ± 0.08, n=25; p < 
0.01) and week 1 to week 12 (0.47 ± 0.05, n=20; 0.90 :t: 0 .11; p < 0.005), but no change 
between weeks 2 and 12. There was also no difference observed when data was expressed 
as units/ml of CAT. Commercial infant fonnula has no CAT activity. Specific activity of 
CAT was not affected by freezing during storage and thawing prior to sample analysis. 
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3.4 Human Milk Pasteurization 
There was no significant difference observed between milk samples before and after 
heat treatment with respect to oxygen consumption measured during oxidative stress. Figure 
3. 7 demonstrates the effectiveness of heat pasteurization on the specific activity of CAT. 
Heating milk samples at 80°C for S minutes is adequate for > 9QO.Io inactivity. The same 
relationship was observed with GSHPx. 
3.5 Antioxidant Enzyme Addition to Formula 
Normal and high·iron formulas were tested for their ability to resist oxidative damage 
with and without the presence of the antioxidant enzymes CAT, SOD and GSHPx. A 
difference (p < 0.001; mean+/· SEM) was reported in total 0 2 consumption (nmoles) over 
time between the human milk ( 44.75 ± 1.66) and both the normal (98. 88 ± 3.11) and high· 
iron ( 168.94 ± 9. 4 7) formulas after the addition of the free radical generator. Addition of the 
enzymes was shown to significantly (p < 0.01) increase the antioxidant capacity by decreasing 
the total oxygen consumption (nmoles) of the normal and high·iron formulas to 66.11 ± 6.48 
and 104.81 ± 8.65 respectively (figure 3.8). 
There was no significant difference observed between the two styles of SimiJac 
formulas tested (figure 3.9), hence the values were combined for comparison purposes. 
Furthermore, it is of interest here that the formulas with high levels of iron exhibited nearly 
a two-fold increase in oxygen consumption compared to the same formula with low iron 
levels. 
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3.6 Iron Addition to Human MHk 
To determine the extent to which high levels of iron in commercial formulas play a 
role in oxygen consumption as a measure of free radical formation and subsequent tissue 
damage, equivalent levels ofFe and Vitamin C (ascorbic acid) were added to HM. This 
addition resulted in a two-fold increase in 0 2 consumption (81.53 nmoles) upon addition of 
HXIXO in the samples containing iron as compared to HM controls (figure 3.1 0). Samples 
with only vitamin C added to HM were not significantly different from controls (49.27 
nmoles). 
3. 7 Correlations 
A significant (R2 = .443, p < 0.05) positive correlation exists between the level of 
rviDA observed in both groups combined at week 2 of lactation and the level of oxygen 
consumption observed during week 1 (figure 3.11). A negative correlation {R2 = -.30, p < 
0 . 01) also exists between the overall level of oxygen consumption observed and the specific 
activity of CAT for values of weeks 1, 2 and 12 combined (figure 3 .12). No correlation was 
found between the level ofMDA and specific activity of CAT at any stage oflactation or with 
all weeks combined. 
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··· CHAPTER 4: DISCUSSION ··· 
4.1 Study Review 
Feeding of newborns with mother's milk provides many benefits leading to optimal 
growth and development. For the compromised LBW infant the same is true. Human milk 
has been demonstrated to have increased nutrient bioavailability, enhanced immunological 
properties, active enzymes and specific growth factors (Pereira, 1995), all of which are 
essential for the health and maturation of these neonates. Furthermore, common neonatal 
infections have been shown to be lower in infants receiving milk from mothers of LBW 
infants than in infants receiving the prescnDed nursery fonnula (Narayanan, 1981 ). 
Breast milk has also been recently shown to exhibit antioxidant properties not seen 
in cow's milk and/or commercial fonnula (Goldm~ 1990). Such antioxidant characteristics 
have been implicated in the sequestering of harmful ROS such as H20 2 (Buescher and 
Mcllheran, 1988) and •ou (Almass, 1997), and therefore aid in the prevention of and 
recovery from oxygen radical-related diseases (Meier & Brown, 1996; Marshall & Roberts, 
1990; Rosenfeld, 1984). It is necessary, then, upon examination of the specific needs of the 
LBW infant, to study the antioxidant properties ofHM compared to the commonly prescribed 
infant formulas, and to make some recommendations for future clinical practice and formula 
development based upon these findings. 
The present study was designed with two objectives in mind. First, to determine if 
there were any observable differences in the antioxidant properties between milk samples from 
mothers ofPT and FT infants, and second, to make an attempt at characterizing the specific 
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components ofHM that enable it to exhibit enhanced antioxidant potential compared to that 
ofinfant formula. What inherent properties oCPT HM provide antioxidant protection against 
free radical-mediated diseases? Is it possible for these protective agents to be incorporated 
into commercial infant formulas and implemented under circumstances where mothers are 
unable provide milk for their infants? The results of the present study are useful in helping 
to determine the answers to these important questions and are discussed in detail in the 
following sections. 
"'It is widely thought that an imbalance between antioxidant defenses and free radical 
activity may be in part responsible for some of the complications of neonatal intensive care" 
(Drury, 1998). Since the premature infant is not simply a small term infant but is also 
developmentally delayed and has decreased enzymatic antioxidant defense systems, it is 
essential to try and boost these systems with the diet. This study has demonstrated yet 
another benefit of HM feeding practices, and has characterized some of the key players 
involved in the fight to maintain a healthy antioxidant balance. 
Human milk samples from weeks one, two and 12 of lactation were collected from 
both study groups for analysis. The first two weeks of lactation were chosen because it is 
during this time that oxidative damage is most severe, and any antioxidant protection that may 
be provided is truly beneficial. Week twelve was chosen as mature milk samples, to examine 
how HM antioxidant properties vary throughout the duration oflactation. Values of n often 
differed within a group from week to week due to subject dropout and/or inconsistency in self 
collection of samples. 
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4.2 Analysis of Study Components 
4. 2.1 Catalase specific activity ill hllllltllf mille 
Heyndrickx ( 1963) was the first and only to report CAT activity in HM. The study 
gave an approximation of the activity of the enzyme to be about 10 times greater than the 
level determined in cow's milk. It appears that all study of the CAT enzyme has been 
reserved for those in the field of dairy science as an examination of its ability to maintain 
cheese stability and shelf-life. 
The present study is the first to report longitudinal values for the specific activity of 
CAT in milk from mothers of both PT and Ff infants. Both groups demonstrated the same 
activity at weeks one, two and 12 oftactation, illustrating that milk from mothers ofLBW 
infants are not compromised with respect to this antioxidant defense system. The activity of 
the enzyme was also seen to increase with the length oflactation to a near two-fold difference 
between week one and week 12 samples. This was opposite to that which was expected, 
since it would seem appropriate for the mother to have an increased expression of the gene 
for the CAT enzyme for the period in which the infant would be at most oxidative risk, and 
could benefit from extra antioxidant protection. 
The uncovering of the presence of CAT in both PT and FT human milk is promising. 
It's role may be extremely important in the prevention of the hannful •oH, and therefore the 
prevention of extensive lipid and protein oxidation of the milk constituents themselves; and 
thus may be partially responsible for protecting the infant gut on site, and at other tissue sites 
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throughout the body - provided the enzyme can pass through the leaky gut and into the blood 
stream. 
4.2.2 Antioxidant capacity of pre-term lt1111UU1 milk 
The literature clearly demonstrates that HM ftom mothers ofboth PT and FT infants 
exhibits far greater benefits than that of infant formula (Pereira, 1995; Narayanan et. al., 
1981). This evidence leads to support the hypothesis that there are compounds or systems 
exclusive to HM that provide it with outstanding antioxidant potential. Furthermore, it is also 
commonly held that FT HM composition adjusts itself slightly depending upon the specific 
needs of the newborn. Is the same true for PT HM? If this were the case then milk from 
mothers of LBW infants would exhibit a different antioxidant composition than milk from 
those of healthy FT infants and would vary depending on the severity of the case. 
Pre-tenn HM samples in this study, however, demonstrated the same antioxidant 
characteristics by our tests as did the samples from theFT group. There was the same 
amount oflipid damage, and CAT specific activity at all stages oflactation, clearly illustrating 
that the PT milk samples do not exhibit enhanced antioxidant properties over and above those 
seen in FT milk samples. However, although the PT samples did not contain more 
antioxidant capacity, they were just as effective in resisting oxidative stress and preventing 
the formation ofMDA as were those in theFT group, and much more effective than the infant 
formula. Therefore, despite the filet that increased antioxidant potential was not observed in 
the PT HM group, the results may support the premise commonly found in literature that 
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early HM feeding may lead to a decrease in the incidence of oxygen radical-related diseases 
in neonates. 
In an attempt to explain why the expected outcome was not observed with respect to 
the antioxidant potential of milk from mothers ofLBW infants, it may be safe to suppose that 
the mother may not be physically able to provide enhanced antioxidant protection for her 
infant who. until recently, would not be assumed to have survived such an early birth. 
Advances in technology and clinical interventions now allow infants to be born even as early 
as 24 weeks gestation and survive (Stone, 1999). The mother's body is simply may not be 
prepared to deal with such an underdeveloped child's development, and can only provide the 
maximum antioxidant status that is observed in mothers of term babies. 
4. 2. 3 Protective effects of 1111tioxida11t e11zymes 
Human milk and infant formulas do not differ a great deal in their amounts of 
nonenzymatic antioxidants such as vitamin E and vitamin C (Appendix A). These 
components are commonly added to infant formulas by manufacturers as essential 
components to the infant diet. Infant formulas, however do not contain active antioxidant 
enzymes. During the processing procedures of formula preparation, the cow's milk used to 
form the protein base of the formula is pasteurized to ensure the product is free from 
bacteria. As a result enzyme activity is lost and therefore cannot provide enzymatic defenses 
to free radical attack. As wen. non-human milk sources in their natural state do not contain 
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the same levels of antioxidant enzymes found in HM (Heyndrickx, 1963; Shahan et. al., 
1980). 
It was expected, then that the antioxidant enzymes CAT, SOD and GSHPx present 
in the mothers milk would play a role in providing the HM with its antioxidant capability in 
vitro, and that these antioxidant enzymes in the protection of mother's milk would be capable 
of crossing the neonatal gut intact and increase antioxidant status and prevent neonatal 
disease. This result would also have provided evidence that HM antioxidant enzymes may 
also play a role in effectively sequestering free radicals directly at the site of inflammation in 
the infant gastrointestinal tract. However, upon pasteurization of the HM, its antioxidant 
properties were not compromised upon oxidative stress. The fact that there was no change 
observed in the protective properties of HM foUowing enzyme inactivation indicates that 
either the enzymes are not involved in the sequestering of free radicals in HM at all, or that 
HM exhibits alternate, and equally-effective, means of dealing with excess oxidative stress and 
does not depend solely upon the known antioxidant enzyme defense systems. 
The latter premise, that HM may have an alternate method of dealing with free 
radicals, and that the activity of the antioxidant enzymes cannot be totally ignored takes 
precedence over the first upon examination of the results observed following the addition of 
the same antioxidant enzymes to infant formula. The antioxidant enzymes CAT, SOD and 
GSHPX, when added together to infant formula were shown to provide increased protection 
against oxidative stress and lipid damage caused by free radical attack. This indicates that the 
proteins are active and are likely working with other systems in the HM and functioning as 
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antioxidants, however to a lesser degree than expected. Research pertaining to these findings 
has not been available up until this point, therefore it is necessary to reconsider the 
participation of antioxidant enzymes in HM. Moreover, the addition of these protective 
agents to clinically administered infant formulas may help reduce the harmful effects of excess 
oxidative stress and inflammatory induced ROS, resulting in reduced symptoms, faster 
recovery and normal development. 
The most common cause-effect relationship between an antioxidant enzyme and 
common oxygen radical-related disease occurs with SOD. SOD has been recendy found to 
be highly active in HM (Willinger et. al., 1990; Friel, 1998, personal communication) and 
subcutaneous administration of the enzyme to LBW infants has been shown to reduce the 
onset ofBPD (Rosenfeld et. al., 1984) and motor neuron degeneration (Gurney et. al., 1994). 
GSHPx in HM has also demonstrated functional and catalytic similarities with the plasma 
enzyme (Hamosh, 1995), and has been observed to protec:t milk lipids from oxidation (Ellis 
et. al., 1990). In the present study CAT has been found to be present and active in both PT 
and FT milk and therefore may also provide protection by decomposing the ROS, H20~ and 
preventing the formation of the more reactive •oH in the neonatal gut and in other tissues, 
including the retinas, lungs, and brain. Each of these enzymes, then, if added to neonatal 
formula may provide the same protective effects observed in HM. 
If a mother is physically incapable of providing milk for her LBW infant or chooses 
not to breastfeed, an alternative source of nourishment has to be considered. Administering 
a neonatal formula that contains added 'active' antioxidant ingredients may prove to be 
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beneficial in minimizing the degree of oxidative damage that would otherwise be no less than 
severe. 
4.2.4 Iron as a free radical generator informMIII 
The action of iron in the body is a paradox. In ample quantities and under proper 
storage while attached to protein it is an essential element to ceU function and metabolism, 
but when found in free form it is toxic and damaging to tissues (Herben et. al., 1994). 
Herbert's group states that because of ats ability to switch back and forth between ferrous and 
ferric states, iron can be both a strong biological oxidant and a good reductant. Most of the 
•oH generated during cell metabolism comes from the iron-dependant reduction of H10 2 
(Halliwell & Gutteridge, 1986). Therefore, if iron levels are high, there may be an increased 
risk of tissue damage and onset of oxygen radical-related diseases ofprematurity. 
When ferrous iron reduces H10 2 to produce •oH it becomes ferric iron. In the 
presence of vitamin C, the iron gets converted back to its ferrous state and is again available 
to begin another cycle of•oH formation if it is not sequestered by the iron storage or transfer 
proteins. Vitamin C and iron are found in high quantities in most neonatal infant formul~ 
and potentially at levels which allow for a source of free iron that cannot be sequestered and 
is capable of initiating free radical reactions which have been shown to lead to tissue damage 
and neonatal disease. 
In the present study, when iron was added to HM at equivalent levels commonly 
found in neonatal infant fonnula, there was a much greater increase of oxygen consumption 
observed indicating that the iron was playing a role in propagating free radical reactions. As 
well, preliminary data was obtained demonstrating a decreased production of free radicals in 
infant formula upon the addition of the iron binder diethylenetriaminepentacetic acid (DTP A), 
but there was suspicion that the DTP A was simply producing a more reducing environment 
in the reaction mixture, interfering with the HXIXO reaction and therefore preventing any 
oxidation from occurring, rather than simply binding the free iron. It was observed that as 
the amount ofDTP A was increased, there was no oxygen consumption upon the addition of 
HXIXO indicating an inhibition in the production of free radicals. More research is required 
here. 
Comparing the response of the low and high-iron infant formula to oxidative stress, 
it is apparent that the high level of iron is responsible for increased free radical formation. 
The high iron formulas ( 12 mg/L) demonstrated a two-fold increase in the amount of oxygen 
consumed compared to the same formulas containing low amounts of iron (1.5-3.0 mg/L). 
Again this illustrates that such extreme levels ofiron may indeed be involved in the production 
of excess free radicals in the LBW infant gut following ingestion of high-iron formula. This 
may aggravate symptoms of chronic inflammation, or even initiate the process of disease 
development in the infant gut or throughout the body if the excess iron is not adequately dealt 
with. 
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4.3 Clinical Implications 
The findings observed in the present study provide interesting insights into present 
clinical practices regarding the neonate without inflicting unnecessary oxidative damage. First 
of all, there is a common relationship between the amount of oxygen administered to a LBW 
infant following birth and the degree of disease onset as measured by MDA levels in plasma 
(Friel, 1998). This coincides with the results of the MDA analysis in the present study, where 
there was an increase of lipid damage observed in samples that were also noted to have 
increased oxygen consumption, and therefore less ability to resist oxidative stress. The 
amount of oxygen provided is a difficult decision, since it is necessary to deal with respiratory 
distress syndrome commonly found in the underdeveloped lungs of LBW infants. As 
illustrated by Friel, if excess oxygen is administered the result is increased tissue damage due 
to the formation of free radicals, and from the present data, is most likely in the presence of 
excess iron. 
Secondly, HM has been shown to provide much better antioxidant protection than that 
of commonly administered neonatal formulas (Kovar et. al., 1984; Meier and Brown 1996). 
Although there appears to be non-enzymatic antioxidant systems at work in human milk when 
enzymes are inactive, the inverse correlation found between the amount of CAT observed and 
the corresponding levels of oxygen consumption and MDA following stress throughout the 
duration oflactation, is indicative of the protective ability ofHM against free radical damage. 
This supports the neonatal recommendations to involve the incorporation of HM feeding 
practices for LBW infants where poSSible and it is practical to do so. 
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4.4 Future Research Recommendations 
The following list is a set of recommendations for possible future research related to 
the field of infant feeding and antioxidant properties ofHM. The suggestions given are based 
upon the findings of the present study, and would help provide further evidence for the claims 
made as well as provide new and valuable insight into the specific antioxidant systems now 
know to be present in mother's milk. Such information would prove to be valuable in clinical 
settings when trying to detennine the most effective and practical form of intervention for 
LBW infants. 
1. Sephadex column fractionation ofHM to separate the proteins by molecular weight. 
This will help determine if the enhanced antioxidant properties observed are attributed 
in part to small molecule antioxidants not yet identified. Since antioxidant capacity 
is not lost with pasteurization, the enzymes are clearly not the only agents involved. 
2. An examination ofHM antioxidant enzyme stability in the infant gut. Active proteins 
such as apolactoferrin have been found in infant feces. This indicates that specific 
whole protein molecules may remain intact in the infant digestive tract, and may pass 
unaltered though the 'leaky gut'. Active antioxidant enzymes from mother's milk may 
behave in the same fashion and be capable of providing the LBW infant with added 
protection against excess oxidative stress. 
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3. Formula-fed LBW infants have higher incidence of oxygen-related disease states than 
those fed HM. Therefore fortification of common pre-term infant formula with 
antioxidant enzymes may prove effective in decreasing symptoms related to oxidative 
stress. It is necessary to perform a clinical trial involving enzyme fortification and 
subsequently observe the degree of onset of symptoms related to common oxygen 
radical-related diseases. 
4. A re-evaluation of the presence of high levels ofFe (12 mg/ml) in infant formulas 
intended for low binh weight infants. In the present study iron has been implicated 
as a free radical generator, which potentially leads to a perpetuation of common 
neonatal disease. 
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··· CHAPTER S: CONCLUSIONS ··· 
The literature provides a powerful argument for the role of reactive oxygen species 
in many of the diseases related to low binh weight infants. The underdevelopment and lack 
of adequate enzymatic defenses in these newborns, along with the clinical requirements to use 
high oxygen levels to treat respiratory distress are important contributors to this oxidative 
stress. The extent of such oxidative damage is very often related to poor clinical outcome and 
physical development in many of these babies. Advances in present clinical feeding practices 
and the successful development of antioxidant fonnulations may provide a means of 
effectively dealing with oxygen-related diseases in neonates and ensuring adequate growth 
and development. The following points outline the major findings of the present study and 
demonstrate hope that the results will assist in the achievement of these goals. 
+ Milk from mothers of pre-term infants does not differ from that of milk from mothers 
of fuU-tenn infants in providing protection against oxidative damage. In the present 
study, samples from both the PT and FT milk groups at all stages of lactation 
analyzed, demonstrated the same response to oxidative stress, the same level ofMDA 
(as a measure of lipid oxidation) following stress, and no difference in the specific 
activity of the antioxidant enzyme catalase. 
+ Antioxidant enzyme systems may not be the only mechanisms of providing human 
milk with its added antioxidant capabilities. Although the addition of catalase, 
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superoxide dismutase and glutathione peroxidase to infant formula was able to 
provide it with added antioxidant potential, pasteurization of the human milk, as a 
means of enzyme inactivation, was unable to diminish the antioxidant capabilities of 
the human milk. This indicates that human milk may contain other non-enzymatic free 
radical-sequestering mechanisms not yet known. 
+ Speculation: Iron in infant formula increases free radical formation and potentially 
increases risk of oxygen radical-related disease in LBW infants. In the present study, 
the high-iron formulas were observed to consume a much greater amount of oxygen 
upon addition of a free radical generator than did the same formulas with low iron. 
Furthermore, addition of iron to human milk also resulted in a two-fold increase in 
oxygen uptake upon oxidative stress. 
+ Addition of antioxidant enzymes naturally found in mothers milk to infant fonnula 
may help protect the milk from free radical formation. Formula composition for low 
birth weight infants is constantly being adjusted to provide the maximum benefit for 
the compromised neonate. The results of the present study indicate a possible 
protective role of the addition of catalase, superoxide dismutase and glutathione 
peroxidase to neonatal infant formulas, which may aid in oxygen radical-related 
disease prevention and/or treatment. 
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··· APPENDIX A: MILK COMPOSmONS ··· 
(Nutrients per liter) 
BumuMllk* s~ Special care• Sialilac• Advuce• 
wi .. Irua24 widl Iroa 
(Low lroll)** (Low 11'011)** 
Energy, Cal 700 806 680 
Volume, ml 1000 1000 1000 
Protein, g 10.3 21.8S 14.0 
Source . Nonfat milk and whey Nonfat milk and whey 
protein CODCeDtralcs protein c:oocentratcs 
Fat, g 44.0 43.79 37.0 
Source . Medium chain Medium cbaiD 
triglyceride, soy & triglyceride. soy & 
coconut oils coconut oils 
Linoleic Acid. mg 
-
S64S ssoo 
Carbobydrate, g 69.0 8S.S 71.0 
Source . Com syrup solids & Lactose 
lactose 
Vitamins 
Vitamin A, IU 3300(+ betKarotcne) 10081 2030 
Vitamin D, IU 4-97 1210 406 
Vitamin E, IU 20 32.3 20 
Vitamin K. meg . 97 S4 
Thiamine. meg 1000 2016 680 
Riboflavin, meg 400 sooo 1000 
Vitamin B6, meg 200 2016 400 
Vitamin B,l, meg .30 4.44 1.7 
Niacin, meg 1800 40323 7100 
Folic Acid. meg 13.0 298 100 
Pant. Acid. meg 2400 1S323 3040 
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a ....... Milk* Simila• Special Care• Similace Adv__, 
witlllr'Oil 24 witlllnll 
(Low .... J•• _(J.Anr lroll)•• 
Biotin.. meg 10 298.4 30 
Vitamin C, mg so 298 61 
Choline, mg 
-
81 110 
Inositol, mg 
-
44 32 
Minerals 
Calcium, mg 330 14.52 527 
Phosphorus, mg 140 806 280 
Magnesium. mg 30 96.8 40 
Iron. mg .so 14.52 (2.98) 12.0 (l.S) 
Zinc. mg 2.8 12.1 S.l 
Manganese, meg 
-
97 34 
Copper. meg .so 2016 610 
Iodine, meg 
-
48 41 
Selenium, meg 
-
14 . .5 lS.S 
Sodium. mg 170 347 160 
Potassium, mg .500 1040 710 
Chloride. mg 420 653 439 
. . 
* From Geigy Sctentific tables, 1981 
*From Abbott Industries, Ross Infant Fonnula product directory. 
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··· APPENDIX B: SUBJECT CONSENT FORM ··· 
FACULTY OF MEDICINE 
MEMORIAL UNIVERSITY OF NEWFOUNDLAND 
ST. JOHN'S, NEWFOUNDLAND AlB 3V6 
CONSENT TO PARTICIPATE IN BIO-MEDICAL RESEARCH 
TITLE: ANTIOXIDANT STATUS IN PREMATURE INFANTS 
INVESTIGATOR(S): James K. Friel, Wayne L. Andrews, Brian S. Simmons, Khalid Aziz 
You have been asked to participate in a research study. Participatioa in this study is entirely 
voluntary. You may decide not to participate or may withdraw from the study at any time without 
affecting your normal treaaneo.t. 
Confidentiality of information concerning participants will be maintained by the investigator. The 
investigator will be available during tbe study at all times should you have any problems or 
questions about the study. 
1. Purpose of study: 
The purpose of this study is to determine if human milk bas better antioxidant protective properties 
for infants than does fonnula feeding. Because the premature infimt is UDderdeveloped in terms of 
its defences. it may be that mocbers milk bas extra benefits for these infants early in life. We 
would like to collect milk samples from mothers of both premature aDd fuU-tenn infants aud assess 
whether this is true. 
2. Description of procedures and tests: 
Once you have decided to breastfeed, we would like to collect 10 ml of milk ftom one feediDg a 
week for 12 weeks. We would ask that for one feeding you use the breast pump in hospital or that 
we will provide to remove all your milk ftom one breast. At that time you cao give us the milk we 
need and give the remainder to the in&ut. 
We also wish to get some informatioo from you and ask your pennission to obtain tbat 
information from hospital reCords. 
3. Duration of subjects participatioa: 
We ask you to be enrolled during the first week of your infants life. We ask that you provide milk 
Wttil 12 weeks after the birth of your infant. 
4. Foreseeable risks, discomforts, or incoaveaieaces: 
The only inconvenience will be milk collection. 
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S. Benefits which tbe subject may receive: 
There will be no direct benefits to you or your infant. 
6. Alternative procedures or treatmeat for those not mteriD& the study: 
If you choose not to enter the study your infant will receive the normal care that they would receive 
at any time. 
7. Liability Disclaimer Statemeat: 
Your signature on this fonn indicates that you have understood to your satisfaction the information 
regarding your participation in tbe research project and agree to participate as a subject. In no way 
does this waive your legal rights nor release the investigators or involved institutions &om their 
legal and professional responsibilities. 
I, _____________ ___, the undersigned. agree to my participation or to 
the participation of ___________ (my child, ward, relative) in tbe research 
study described. 
Any questions have been answered and I understand what is involved in the study. I realise that 
participation is voluntary and that there is no guarantee that I will benefit from my involvement. I 
acknowledge that a copy of this fonn has been offered to me. 
(Signature of Participant) (Date) 
To be signed by investiptor: 
To the best of my ability I have fuUy explained to the subject the nature of this research study. I 
have invited questions and provided aaswers. I believe that tbe subject fuUy understaods tbe 
implications and voluntary nature ofthe study. 
(Signature of Investigator) (Date) 
Phone Number:--------------




